Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

CUSIP: 984241109

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
45,101,565
Total 13F shares
22,993,565
Share change
+2,760,707
Total reported value
$373,875,065
Put/Call ratio
129%
Price per share
$16.26
Number of holders
94
Value change
+$49,054,572
Number of buys
43
Number of sells
60

Quarterly Holders Quick Answers

What is CUSIP 984241109?
CUSIP 984241109 identifies YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) as of Q1 2024

As of 31 Mar 2024, Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) was held by 94 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,993,565 shares. The largest 10 holders included BlackRock Inc., Paradigm Biocapital Advisors LP, Sofinnova Investments, Inc., VANGUARD GROUP INC, Polar Capital Holdings Plc, Point72 Asset Management, L.P., D. E. Shaw & Co., Inc., STATE STREET CORP, PICTET ASSET MANAGEMENT Holding SA, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 95 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
93
Q1 2024 holders
94
Holder diff
1
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 Value $ Q1 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .